A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer

Abstract

Only a small proportion of stage II CRC patients could benefit from adjuvant therapy. The 11-PPI-Mod as a potential predictor could be helpful to distinguish this sub-group with favorable outcome.